# Biomarker Study in Participants With Migraine

> **NCT02766517** · EARLY_PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 37 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Capsaicin

## Key facts

- **NCT ID:** NCT02766517
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-28
- **Primary completion:** 2017-01-01
- **Final completion:** 2017-01-01
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2019-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02766517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02766517, "Biomarker Study in Participants With Migraine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02766517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*